|
|
Gastric/Esophageal Studies Currently Recruiting Participants at Simmons Cancer Research Center at Southern Illinois University
| Protocol Title |
Study # |
Study Group |
| A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma |
CTSU-RTOG 1010 |
CICCOP |
| Randomized Phase II Study of Paclitaxel With or Without the Anti-IGF-IR mAb Cixutumumab (IMC-A12) as Second Line Treatment for Patients With Metastatic Esophageal or GE Junction Cancer |
ECOG E2208 |
CICCOP |
| A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Who Are Treated Without Surgery |
CTSU/ RTOG 0436 |
RTOG |
Although our objective is to provide an updated listing of available clinical trials please note that a listing here does not guarantee that a trial is open or available to any specific patient and that there may be additional trials available that are not listed. Complete information is only available from a treating physician.
Contact Information:
Simmons Cancer Institute Clinical Trials Office
Mail Code 9677 Fax (217) 545-6823
- Kathy Robinson, PhD,
Director of Clinical Trials
(217) 545-1946
-
Allicent Curry, RN,BSN, OCN
Research Nurse
(217) 545-7929 -
-
-
-
-
SIU Behavioral & Psychosocial Oncology
- Anna Wiggins, MS, LCPC
(217) 545-5408
-
SIU COG
- Carol Peterson, RN, CCRP (217) 545-7377
SIU IM
- Amanda Fogleman, B.S. (217) 545-0592
- Krista Whitlock (217) 545-7750
SIU Thoracic
- Theresa Boley, RN, MSN, APN/FNP-BC, CCRP (217) 545-5000
-
- Cathy Leslie, RN, CCRP (217) 545-8184
- Mary Ray, MS (217) 545-7420
-
RTOG: Radiation Therapy Oncology Group:
- Diana Weyhenmeyer, RN, MA, OCN (217) 544-6464 ext. 45591
CICCOP: Central Illinois Community Clinical Oncology Program
Memorial Medical Center CICCOP Research Contacts:
Treatment/Cancer Control:
- Holly Thomas (217) 788-4178
- Stephanie Allbritton (217) 788-3544
- Brooke Trickey (217) 217-788-3560
- Karen Graber (217) 588-2961
- Chrissy Tucker (217) 788-4444
Sunny Hampsey (217) 788-4233
Back to Open Clinical Trials
|
 |
|
